Redirect Notice

Looks like you clickedhttps://www.gov.uk/drug-safety-update/lemtrada-alemtuzumab-and-serious-cardiovascular-and-immune-mediated-adverse-reactions-new-restrictions-to-use-and-strengthened-monitoring-requirements

If you do not want to visit that page, you can close this browser tab.